EN DE

Stock Market Valuation Statistics › Sectors

Healthcare Stock Valuation

How expensive are Healthcare stocks compared with fair value? This figure comes from our valuation of 35,000+ stocks and updates monthly. Free to cite with attribution.

As of: 2026-08-01 · August 2026 · updated monthly

Healthcare vs. fair value
+37.3 %
above aggregate fair value
Rank
#3 / 11
by valuation, most expensive first
vs. global market
+34.6 %
Healthcare is more expensive

Healthcare stocks currently trade +37.3 % above their estimated fair value, ranking 3 of 11 sectors we track. That is more expensive than the global market (+34.6 %).

All sectors compared

#Sector% above fair value
1 Information Technology +100.1 %
2 Industrials +46.0 %
3 Health Care +37.3 %
4 Consumer Staples +34.9 %
5 Energy +32.3 %
6 Materials +31.6 %
7 Utilities +30.8 %
8 Real Estate +30.3 %
9 Consumer Discretionary +22.8 %
10 Communication Services +15.1 %
11 Financials +1.7 %

Most undervalued Healthcare stocks

Names with the largest upside to fair value at solid quality:

CompanyUpsideQuality
PLUXEE NV+139.0 %67/100
Universal Health Services Inc+132.3 %66/100
Sonic Healthcare Ltd+120.8 %61/100
China National Medicines Corp Ltd+112.6 %62/100
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt+111.9 %74/100
Fresenius Medical Care Corporation+94.9 %64/100
S N Nuclearele+88.6 %61/100
Astellas Pharma Inc+87.1 %74/100
PTC Therapeutics Inc+83.8 %61/100
Medipal Holdings Corp ADR+81.3 %63/100
Cigna Corp+78.6 %67/100
Solventum Corp.+75.0 %61/100

See all undervalued stocks →

Cite or reuse this figure

Suggested citation: Fair Value Calculator, Stock Market Valuation Statistics (August 2026). https://www.fairvalue-calculator.com/stock-market-valuation-statistics/sector/health-care

Free to use under CC BY 4.0. Raw data as CSV/JSON and code samples: /developers

Methodology: fair value per stock from 21 independent valuation models, quality from 25 fundamental factors, backed by a 34-year backtest. "% above fair value" = capitalisation-weighted gap of price to the aggregate fair value of the group. For information, not investment advice.